TCV Trust & Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.1M Sell
98,918
-695
-0.7% -$162K 1.9% 13
2026
Q1
$24.3M Sell
99,613
-1,870
-2% -$436K 2.04% 11
2025
Q4
$21M Buy
101,483
+1,465
+1% +$290K 1.7% 15
2025
Q3
$18.5M Buy
100,018
+1,810
+2% +$310K 1.55% 15
2025
Q2
$15M Sell
98,208
-541
-0.5% -$83.2K 1.31% 26
2025
Q1
$16.4M Buy
98,749
+23
+0% +$3.6K 1.52% 23
2024
Q4
$14.3M Buy
98,726
+1,820
+2% +$282K 1.32% 25
2024
Q3
$15.7M Sell
96,906
-359
-0.4% -$57.2K 1.41% 26
2024
Q2
$14.2M Buy
97,265
+834
+0.9% +$124K 1.36% 29
2024
Q1
$15.3M Sell
96,431
-2,229
-2% -$355K 1.46% 23
2023
Q4
$15.5M Sell
98,660
-1,121
-1% -$172K 1.56% 19
2023
Q3
$15.5M Buy
99,781
+1,445
+1% +$238K 1.71% 15
2023
Q2
$16.3M Sell
98,336
-924
-0.9% -$149K 1.73% 13
2023
Q1
$15.4M Buy
99,260
+1,935
+2% +$312K 1.71% 14
2022
Q4
$17.2M Buy
97,325
+647
+0.7% +$112K 1.95% 12
2022
Q3
$15.8M Buy
96,678
+2,882
+3% +$488K 2.01% 9
2022
Q2
$16.6M Buy
93,796
+1,557
+2% +$277K 1.99% 10
2022
Q1
$16.3M Buy
92,239
+1,120
+1% +$191K 1.74% 15
2021
Q4
$15.6M Buy
91,119
+647
+0.7% +$106K 1.55% 16
2021
Q3
$14.6M Sell
90,472
-4
-0% -$682 1.62% 17
2021
Q2
$14.8M Buy
90,476
+205
+0.2% +$33.9K 1.62% 16
2021
Q1
$14.8M Sell
90,271
-324
-0.4% -$52.4K 1.72% 15
2020
Q4
$14.3M Sell
90,595
-1,728
-2% -$255K 1.73% 14
2020
Q3
$13.7M Buy
92,323
+960
+1% +$142K 1.85% 10
2020
Q2
$12.8M Sell
91,363
-6,383
-7% -$930K 1.82% 14
2020
Q1
$12.8M Sell
97,746
-6,131
-6% -$870K 2.1% 10
2019
Q4
$15.2M Sell
103,877
-134
-0.1% -$18.2K 1.84% 14
2019
Q3
$13.5M Buy
104,011
+852
+0.8% +$112K 1.74% 17
2019
Q2
$14.4M Buy
103,159
+797
+0.8% +$110K 1.86% 15
2019
Q1
$14.3M Sell
102,362
-869
-0.8% -$116K 1.89% 11
2018
Q4
$13.3M Buy
103,231
+869
+0.8% +$121K 1.95% 12
2018
Q3
$14.1M Sell
102,362
-716
-0.7% -$95.1K 1.89% 11
2018
Q2
$12.5M Buy
103,078
+1,541
+2% +$192K 1.75% 13
2018
Q1
$13M Buy
101,537
+2,216
+2% +$300K 1.87% 12
2017
Q4
$13.9M Sell
99,321
-1,536
-2% -$214K 1.94% 11
2017
Q3
$13.1M Buy
100,857
+38
+0% +$5.04K 1.94% 10
2017
Q2
$13.3M Sell
100,819
-1,088
-1% -$139K 2.02% 9
2017
Q1
$12.7M Buy
101,907
+586
+0.6% +$70K 1.94% 10
2016
Q4
$11.7M Buy
101,321
+1,854
+2% +$214K 1.89% 11
2016
Q3
$11.8M Buy
99,467
+2,216
+2% +$269K 1.99% 9
2016
Q2
$11.8M Buy
97,251
+3,906
+4% +$444K 2.05% 9
2016
Q1
$10.1M Buy
93,345
+7,161
+8% +$741K 1.82% 11
2015
Q4
$8.85M Buy
86,184
+2,788
+3% +$280K 1.57% 16
2015
Q3
$7.79M Buy
83,396
+2,318
+3% +$224K 1.41% 18
2015
Q2
$7.9M Buy
81,078
+4,935
+6% +$494K 1.3% 23
2015
Q1
$7.66M Buy
76,143
+9,323
+14% +$948K 1.24% 23
2014
Q4
$6.99M Buy
66,820
+30,346
+83% +$3.2M 1.15% 25
2014
Q3
$3.89M Buy
36,474
+265
+0.7% +$27.5K 0.66% 53
2014
Q2
$3.79M Buy
36,209
+1,949
+6% +$197K 0.62% 54
2014
Q1
$3.37M Sell
34,260
-97
-0.3% -$8.99K 0.57% 61
2013
Q4
$3.15M Buy
34,357
+2,509
+8% +$231K 0.54% 61
2013
Q3
$2.76M Buy
31,848
+550
+2% +$49.3K 0.54% 63
2013
Q2
$2.69M Buy
+31,298
New +$2.66M 0.55% 61

Other funds holding JNJ

TCV Trust & Wealth Management's JNJ Position: Q2 2026 in Review

TCV Trust & Wealth Management reduced its Johnson & Johnson (JNJ) stake by 0.7% in Q2 2026, selling an estimated $162K and leaving 98,918 shares worth $25.1M. The position accounts for 1.9% of the portfolio, ranked #13.

TCV Trust & Wealth Management first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • TCV Trust & Wealth Management held 98,918 shares of Johnson & Johnson worth $25.1M as of Q2 2026.
  • TCV Trust & Wealth Management sold 695 Johnson & Johnson shares in Q2 2026, an estimated $162K.
  • Johnson & Johnson made up 1.9% of TCV Trust & Wealth Management's portfolio in Q2 2026, its #13 holding.
  • TCV Trust & Wealth Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on TCV Trust & Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.